Table 2 Chemical parameters and cholesterol efflux capacity at baseline and follow up.

From: Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes

 

Non Diabetes (n = 48)

Diabetes Mellitus (n = 37)

P Value

Baseline

Total Cholesterol, mg/dl

152.0 ± 42.1

155.1 ± 48.7

0.94

LDL Cholesterol, mg/dl

87.8 ± 37.4

85.5 ± 42.7

0.318

HDL Cholesterol, mg/dl

42.9 ± 12.6

39.3 ± 12.6

0.13

Triglyceride,, mg/dl

106.5 ± 59.8

155.0 ± 148.8

0.11

ApoA1, mg/dl

121.4 ± 24.5

118.5 ± 27.1

0.48

hs-CRP, mg/dl

3.2 ± 5.5

3.8 ± 5.9

0.13

HbA1C, % (mmol/mol)

5.9 ± 0.4 (41 ± 4.4)

8.3 ± 2.0 (67 ± 21.9)

<0.001

Cholesterol Efflux Capacity

81.1 ± 0.1

80.4 ± 0.2

0.68

Follow up

Total Cholesterol, mg/dl

119.8 ± 29.9

109.4 ± 29.2

0.045

change

−32.3 ± 39.0

−45.7 ± 45.0

0.11

p value

<0.001

<0.001

 

LDL Cholesterol, mg/dl

55.3 ± 28.3

43.4 ± 20.6

0.06

change

−32.5 ± 32.5

−41.1 ± 41.8

0.37

p value

<0.001

<0.001

 

HDL Cholesterol, mg/dl

44.5 ± 11.6

41.2 ± 17.7

0.058

change

1.5 ± 8.8

1.9 ± 13.4

0.53

p value

0.261

0.76

 

Triglyceride, mg/dl

96.1 ± 49.0

120.6 ± 81.0

0.14

change

−10.4 ± 49.8

−34.4 ± 154.7

0.66

p value

0.18

0.14

 

ApoA1, mg/dl

132.1 ± 20.7

120.7 ± 25.0

0.011

change

11.38 ± 24.7

1.6 ± 16.0

0.049

p value

0.003

0.47

 

hs-CRP, mg/dl

2.17 ± 3.5

3.23 ± 5.0

0.034

change

−0.9 ± 4.1

−0.5 ± 5.0

0.62

p value

0.001

0.058

 

HbA1c

6.0 ± 0.5 (42 ± 5.5)

8.2 ± 1.6 (66 ± 1.6)

<0.001

change

0.04 ± 0.2 (0.4 ± 2.2)

−0.11 ± 1.6 (−1.2 ± 17.5)

0.27

p value

0.34

0.62

 

Cholesterol Efflux Capacity

85.3 ± 0.1

83.7 ± 0.2

0.20

change

0.04 ± 0.1

0.03 ± 0.7

0.83

p value

0.007

0.015

 
  1. Values are mean ± SD
  2. *LDL denotes low density lipoprotein cholesterol, HDL high density lipoprotein cholesterol, Apo-AI apolipoprotein AI, hs-CRP high-sensitivity C-reactive protein.